Literature DB >> 6709905

Splenic infarction, a complication of transcatheter hepatic arterial embolization for liver malignancies.

K Takayasu, N Moriyama, Y Muramatsu, M Suzuki, T Ishikawa, K Ushio, H Matsue, M Sasagawa, T Yamada.   

Abstract

Splenic infarction was recognized in five of 37 patients who had hepatic neoplasms and who were being examined after transcatheter hepatic arterial embolization by CT during a follow-up study. CT images of the spleen showed multiple low density areas of a wedge or fused-wedge shape in most patients and of a rod or round shape in others. These low density areas decreased in size in time, and in two patients they disappeared in three months. Three of the five patients complained of a dull pain in the left upper quadrant that did not require any treatment. CT is effective in the diagnosis and assessment of splenic infarction. Awareness of this complication will help to avoid it when hepatic arterial embolization is being performed.

Entities:  

Mesh:

Year:  1984        PMID: 6709905     DOI: 10.1148/radiology.151.2.6709905

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  The role of surgery in the management of unusual complications of transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K S Jeng; H J Ching
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

2.  Fatal septic complication of transcatheter chemoembolization for hepatocellular carcinoma.

Authors:  T Hashimoto; T Mitani; H Nakamura; S Hori; T Kozuka; Y Kobayashi; A Nakata; T Tsujimura
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

3.  Alleviation of gallbladder complications by treatment of hepatic arterial embolization with caerulein.

Authors:  K Akamatsu; S Miyauchi; K Ohshima; S Okita; Y Yasuhara; H Mogami; Y Ohta; K Hamamoto
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.